Supernus Pharmaceuticals Inc. News
Supernus Higher as Pediatric ADHD Drug Is Cleared by FDA
Supernus shares are higher after the Food and Drug Administration cleared the company to market a new ADHD drug for children.
Supernus Up on Report of Progress With ADHD Treatment
Supernus said that a Phase 3 trial 'met the primary endpoint ... compared to placebo in improving the symptoms of ADHD.'
Biogen, UnitedHealth: 5 Top Stock Gainers for Wednesday
Super Micro Computer, Biogen, Neurocrine Biosciences, Supernus Pharmaceuticals and UnitedHealth.
CVS Health, Coca-Cola, Norfolk Southern: 'Mad Money' Lightning Round
Jim Cramer is bullish on CVS Health, Coca-Cola, Norfolk Southern, IBM and Randgold Resources.
Victory Comes From Leadership: Cramer's 'Mad Money' Recap
Jim Cramer says that whether it's at West Point or on Wall Street, leadership comes from loyalty, innovation, and the first-mover advantage.
MediWound Shares Lower After Pricing Stock Offering - Biotech Movers
MediWound priced an underwritten public offering of 4.4 million shares at $5 apiece.
UPS, McKesson, Chegg and More: 'Mad Money' Lightning Round
Here's a look at what Jim Cramer had to say about companies of interest to Mad Money viewers.
Investors Should Ignore Washington: Cramer's 'Mad Money' Recap (Tuesday 7/18/17)
Investors need to focus on earnings and not be distracted by the circus in Washington, Jim Cramer says.
A New Take on the Big Mac (May Be) Headed to U.S. McDonald's Menus
This is very different than the Big Mac you know and love.
We're Enduring 'Housing Recession,' Homebuilders' Economist Says
The builder confidence index breached the break-even measure of 50 in August for the first time since May 2020.